| Předmět: |
|
| Zdroj: |
Genomics & Genetics Weekly; 8/23/2024, p1516-1516, 1p |
| Abstrakt: |
A recent study conducted by researchers at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine in China explored the therapeutic benefits of a traditional Chinese medicine called PaBing-II (PB-II) in treating Parkinson's disease (PD). The study aimed to investigate the mechanisms underlying the effects of PB-II on PD patients. The researchers found that PB-II protected dopaminergic neurons from oxidative stress and inflammation by activating the Nrf2 pathway. These findings contribute to our understanding of the potential application of PB-II in PD treatment and highlight the use of human-induced pluripotent stem cell-derived dopaminergic neurons in Chinese medicine research. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
